GPBAR1 and fatty liver disease: As a decrease of these inflammatory markers is associated with the improvement of fatty liver disease in mice and humans (33), these findings suggested that activation of FXR and TGR5 signaling might be the key step toward the BAs-induced lipid-lowering outcome (in hybrid grouper).